Impossible Foods Pushes FDA for Bloody Soy in Fake Meat Products
Published Date: 3/14/2025
Proposed Rule
Summary
Impossible Foods wants the FDA to approve a new color additive called soy leghemoglobin for use in plant-based meat, poultry, and fish products. This change would let them make their plant-based foods look and taste more like real meat. If approved, it could happen soon and might boost the plant-based food market without extra costs for consumers.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
May Boost Plant-Based Market Without Raising Consumer Prices
Impossible Foods filed a petition to expand use of soy leghemoglobin in plant-based meat, poultry, and fish analogue products (ground and whole cut). The document states that if approved it might boost the plant-based food market and could occur without extra costs for consumers.
Soy Leghemoglobin Could Make Plant-Based Meat More Meat-Like
The FDA received a petition from Impossible Foods to allow soy leghemoglobin as a color additive in plant-based meat, poultry, and fish analogue products (ground and whole cut). If the FDA approves the petition, producers could use soy leghemoglobin to make plant-based foods look and taste more like real meat, and the document says that could happen soon.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
2026-16944, Gardenia Blue Interest Group; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by Gardenia Blue Interest Group (GBIG or petitioner), c/o Exponent, Inc., proposing that we amend our color additive regulations to expand the safe use of gardenia (genipin) blue in various foods at levels consistent with good manufacturing practice. The petition also proposes to lower the specification for arsenic in gardenia (genipin) blue.
Previous / Next Documents
Previous: 2025-03750, Petitions for Reconsideration of Action in Rulemaking Proceeding
Some folks from rural wireless groups asked the Commission to rethink parts of a recent rule. This affects companies providing wireless services in rural areas and could change how rules apply to them. Keep an eye out for updates soon, as these petitions might shift the timeline or costs involved.
Next: 2025-04088, Unsafe and Unsound Banking Practices: Brokered Deposits Restrictions; Guidelines Establishing Standards for Corporate Governance and Risk Management for Covered Institutions With Total Consolidated Assets of $10 Billion or More; Regulations Implementing the Change in Bank Control Act; Withdrawal
The FDIC is hitting pause and withdrawing its earlier plans to change rules about brokered deposits, bank leadership, and bank ownership changes. This means banks with $10 billion or more won’t see new rules right now, but the FDIC might bring fresh ideas later. No new costs or deadlines are coming from this move—just a wait-and-see moment.